(Sharecast News) - Creo Medical said on Monday that first-quarter revenue rose about 60% year on year, at the upper end of management expectations, driven by customer adoption, higher procedure volumes and conversion of its commercial pipeline.
The AIM-traded medical device group now expects FY26 revenue growth of 50% to 60%,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE